Novel probiotic Enterococcus faecium IS-27526 supplementation increased total salivary sIgA level and bodyweight of pre-school children: A pilot study

Anaerobe

Volumn 17, Issue 6, 2011, Pages 496-500

  Surono, Ingrid S ^a,b   Koestomo, Fiona P ^c   Novitasari, Nuni ^c   Zakaria, Fransiska R ^c   Yulianasari, ^d   Koesnandar, ^b  

^a UNIVERSITY OF INDONESIA   (Indonesia)

^b Agency for the Assesment and Application of Technology Center for Bioindustrial Technology   (Indonesia)

^c BOGOR AGRICULTURAL UNIVERSITY   (Indonesia)

^d Teluk Naga Public Health Center   (Indonesia)

Author keywords

Dadih; Enterococcus faecium IS 27526; Novel probiotic; Pre school children; Salivary sIgA; Weight gain

Indexed keywords

IS 27526; MALTODEXTRIN; PLACEBO; PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; ENTEROCOCCUS FAECIUM; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE SEQUENCE; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; SALIVA LEVEL; TREATMENT RESPONSE; UNDERWEIGHT; WEIGHT GAIN;

ANIMALS; BODY WEIGHT; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ENTEROCOCCUS FAECIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INFANT; MALE; MILK; PLACEBOS; PROBIOTICS; SALIVA;

ENTEROCOCCUS FAECIUM;

EID: 84655169262     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2011.06.003     Document Type: Article

References (29)

1. Suau A., Bonnet R., Sutren M., Godon J.-J., Gibson G., Collins M.D., et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999, 65:4799-4807.
2. Kelly D., Conway S., Aminov R. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol 2005, 26:326-333.
3. Spiller R., Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis 2009, 41(12):844-849.
4. Cani P.D., Delzenne N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm 2009, 15:1546-1558.
5. Collins M.D., Gibson G.R. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999, 69:1052S-1057S.
6. Fuller R., Gibson G.R. Modification of the intestinal microflora using probiotics and prebiotics. Scand. J Gastroenterol Suppl 1997, 222:28-31.
7. Guidelines for the evaluation of probiotics in food. Working group rep 2002, Food and Health Agricultural Organization of the United Nations and World Health Organization, Food and Health Agricultural Organization of the United Nations and World Health Organization, Washington DC.
8. Collado M.C., Gueimonde M., Hernandez M., Sanz Y.M., Salminen S. Adhesion of selected Bifidobacterium strains to human intestinal mucus and its role in enteropathogen exclusion. JFood Prot 2005, 68(12):2672-2678.
9. Collado M.C., Surono I.S., Meriluoto J., Salminen S. Indigenous dadih lactic acid bacteria: cell-surface properties and Interactions with pathogens. JFood Sci 2007, 72(3):M89-M93.
10. Schiffrin E.J., Brassard D., Servin A.L., Rochat F., Donnet-Hughes A. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 1997, 66:515-520.
11. Borchers M.T., Wesselkamper S.C., Deshmukh H., Beckman E., Medvedovic M., Sartor M., et al. The role of T cells in the regulation of acrolein-induced pulmonary inflammation and epithelial-cell pathology. HEI health review committee. Res Rep Health Eff Inst 2009, 146:5-29.
12. Salminen S., von Wright A., Morelli L., Marteau P., Brassart D., de Vos W.M., et al. Demonstration of safety of probiotics - a review. Int J Food Microbiol 1998, 44:93-106.
13. Akuzawa R., Surono I.S. Fermented milks of Asia. Encyclopedia of dairy sciences 2002, 1045-1048. Academic Press Ltd., London, UK. H. Roginski, J.W. Fuquay, P.F. Fox (Eds.).
14. Surono I.S. In vitro probiotic properties of indigenous dadih lactic acid bacteria. Asian Aus J Anim Sci 2003, 16:726-731.
15. Surono I.S., Hosono A. Antimutagenicity of milk cultured with lactic acid bacteria from dadih against mutagenic terasi. Milchwissenschaft 1996, 51:493-497.
16. Collado M.C., Surono I.S., Meriluoto J., Salminen S. Potential probiotic characteristics of Lactobacillus and Enterococcus strains isolated from traditional dadih fermented milk against pathogen intestinal colonization. JFood Prot 2007, 70(3):700-705.
17. Anthro beta version Feb 17th, 2006: software for assessing growth and development of the world's children 2006, WHO, [cited 2006 Jul 10]. Available from:, WHO, Geneva. http://www.who.int/childgrowth/software/en/.
18. Minium E.W., Clarke R.C., Coladarci T. Elements of statistical reasoning 1999, John Wiley & Sons, New York. 2nd ed.
19. Perdigon G., Vintini E., Alvarez S., Medina M., Medici M. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. JDairy Sci 1999, 82(6):1108-1114.
20. Picard C., Fioramonti J., Francois A., Robinson T., Neant F., Matuchansky C. Review article: bifidobacteria as probiotic agents - physiological effects and clinical benefits. Aliment Pharmacol Ther 2005, 22:495-512.
21. Adolfsson O., Meydani S.N., Russell R.M. Yogurt and gut function. Am J Clin Nutr 2004, 80(2):245-256.
22. Cesena C., Morelli L., Alander M., Siljander T., Tuomola E., Salminen S., et al. Lactobacillus crispatus and its nonaggregating mutant in human colonization trials. JDairy Sci 2001, 84:1001-1010.
23. Jankovic I., Ventura M., Meylan V., Rouvet M., Elli M., Zink R. Contribution of aggregation-promoting factor to maintenance of cell shape in Lactobacillus gasseri 4B2. JBacteriol 2003, 185:3288-3296.
24. Erickson K.L., Hubbard N.E. Probiotic immunomodulation in health and disease. JNutr 2000, 130(suppl):403S-409S.
25. Ouwehand A.C., Kirjavainen P.V., Shortt C., Salminen S. Probiotics: mechanism and established effects. Int Dairy J 1999, 9:43-52.
26. Roitt I., Delves P.J. Roitt's essential immnuology 2001, Blockwell Scientific Publication, London. 10th ed.
27. Jelen P., Lutz S. Functional milk and diary products. Functional foods: biochemical & processing aspects 1998, Technomic Publishing Co. Inc., Lancaster, Basel. G. Mazza (Ed.).
28. Brassart D., Schiffrin E.J. Pre- and probiotics. Essentials of functional foods 2000, An Aspen Publication, Gaithersburg, Maryland. M.K. Scmidl, T.P. Labuza (Eds.).
29. Varnam A.H., Sutherland J.P. Milk and milk products: technology, chemistry and microbiology 1994, Chapman & Hall, London.